Teva Pharmaceutical Industries Limited Announces Launch of Generic Prometrium® Capsules in the United States

March 2, 2012 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today the commercial launch of Progesterone Capsules, 100 & 200 mg, the AB-rated generic equivalent of Abbott Laboratories’ Prometrium® Capsules.

Twitter
LinkedIn
Facebook
Email
Print

Asia Europe